ARTICLE | Clinical News
OncoMed preclinical data
April 9, 2012 7:00 AM UTC
In mouse xenograft models of pancreatic cancer, OMP-59R5 plus gemcitabine significantly reduced cancer stem cell frequency and significantly delayed tumor recurrence upon discontinuation of gemcitabin...